Close Menu

Daniel Gibson says that being able to synthesize new genomes may "dramatically speed up the process of engineering microbes that can carry out tasks such as efficiently producing biofuels or vaccines," as he tells MIT's Technology Review. Last year, Gibson's team at the J. Craig Venter Institute announced that they made a synthetic genome using yeast cells to assemble the oligonucleotides, and Gibson has now developed a way of doing that without the yeast.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.